Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Novartis
Novartis
Kivu Bioscience Inc.
Instituto do Cancer do Estado de São Paulo
Bayer
Alliance for Clinical Trials in Oncology
Actuate Therapeutics Inc.
Eastern Cooperative Oncology Group
Memorial Sloan Kettering Cancer Center